Introduction
Acute and chronic haematogenous osteomyelitis are major clinical problems in Uganda, as in the rest of the developing world (British Medical 7ournal, 1967) . About 200 patients with these conditions are admitted annually to Mulago Hospital. In oontrast to a recent report (British Medical 7ournal, 1969) , most of these-in whom the infecting agent is Staph. aureus-present in the early stages of the disease. Unfortunately, there is an increasing resistance-to penicillin in staphylococci isolated from the Mulago patients. In a study of Staph.
aureus acquired outside hospital in Uganda, 15 % were resistant to benzylpenicillin (Balmer et al., 1970) . In staphylococci from acute ostoomyelitis resistance is more frequently encountered, possibly because of inadequate therapy with penicillin before admission. Of the last 31 cases treated at Mulago 30 were due to staphylococci that were, by routine disc test, resistant to penicillin; though determina-tion of the minimum inhibitory concentration (M.I.C.) sh,owed that some of these patients might have been successfully treated with large doses of penicillin.
It is generally agreed that a bactericidal drug is superior to a bacteriostatic drug for treating acute osteomyelitis. For this reason, and because of the problem of penicillin-resistant staphylococci, the penicillinase-resistant penicillins, methicillin and cloxacillin, and the combination of Fucidin (sodium salt of fusidic acid) and methicillin (Jensen and Lassen, 1969) have been strongly recommended as first-choict antibiotics for the treatment of this condition. At present, however, the only bactericidal drug widely available in Uganda is-penicillin. This is the background to the problem of osteomyelitis as it confronts the clinician in Uganda, and it prompted us to study the recently introduced bactericidal combination, trimethoprim-sulphamethoxazole, in acute osteomyelitis. Trimethoprim is a synthetic and potent inhibitor of folate synthesis. Acting alone, it inhibits the growth of many species of bacteria; in oombination with a sulphonamide-of which sulphamethoxazole seems most suitable-its action against sulphonamide-sensitive organisms is often potentiated, and is thought to be bactericidal Darrell et al., 1968) . In human plasma concentrations of trimethoprim of 1 ,ug./ml. and sulphamethoxazole 20 ,ug./ml. are easily maintained. Balmer et al. (1970) 
Discussion
Antibiotics and general measures alone will cure more than 95% of osteomyelitis treated before the third day of illness, whereas almost 50% of patients seen after this time need surgical drainage of subperiosteal absces3ss and sequestrectomies, despite adequate and prolonged antibiotic therapy (Harris, 1960) . In Uganda, however, the clinician rarely sees acute osteomyelitis during the very early stages. Most patients have radiographic evidence of bone infection when admitted, indicating progressive disease of at least 10 days' duration. Such cases, as Harris showed, usually need surgical drainage of abscesses in addition to adequate chemotherapy.
Many develop chronic osteomyelitis and need sequestrectomy. But for those who recover after adequate antibiotic therapy and drainage of abscesses it is not possible to say to what extent the cure can be attributed to the antibiotic. Clearly, the efficacy of a drug would be best shown by studying its effects in early acute osteomyelitis, before the development of intramedullary or subperiosteal abscesses and before the development of bone necrosis and sequestration.
During the initial phases of the treatment of patients reported here, penicillinase-resistant penicillins were very scarce in Uganda. The combined disc-diffusion tests of staphylococci from Cases 1-5 suggested that trimethoprim-sulphamethoxazole would be effective, as it indeed was. Later, when minimum inhibitory concentrations were determined, a rational basis for this treatment was confirmed for Cases 1, 3, 4, and 5. The strain from Case 2, however, was resistant to sulphamethoxazole. In retrospect, we think that, had the minimum inhibitory concentration tests been available to us at the time, it would have been wiser to treat this patient with cloxacillinif it could have been obtained. The satisfactory response to Bactrim in Case 2 was presumably due to the independent action of trimethoprim, on which it is recommended that one should not rely (Bushby, 1969) . It is well known that acute osteomyelitis has a habit of recurring, and follow-up over a period of years is necessary before infection can be said to have been eradicated. None the less we have a strong clinical impression that trimethoprim-sulphamethoxazole is of value in the treatment of this disease. We suggest that the encouraging results obtained in these cases, four of which were septicaemic and seriously ill, establish an a priori case for the use of this drug combination in acute osteomyelitis when penicillinase-resistant penidillins cannot be used for any reason.
INTRODUCTION
Phenytoin (diphenylhydantoin) is widely used in the treatment of epilepsy and sometimes in the control of cardiac arrhythmias (Bigger et al., 1968) . In an attempt to provide a standard measure of absorption of the drug, oral and intravenous tolerance tests were devised. Unexpectedly, the tolerance curves so obtained showed a double peak.
METHOD
Oral Tolerance Test.-Phenytoin sodium 700 mg. in capsule form (Epanutin) was given as a single dose to fasting adult subjects. Heparinized blood samples for estimation of plasma phenytoin levels were obtained before the drug was given and at the following times afterwards: 30 minutes, one hour, hourly from two to eight hours, 10 hours, and 12 hours. The plasma was separated by centrifugation, frozen, and stored until estimated.
Intravenous Tolerance Test.-Phenytoin sodium 250 mg. was injected intravenously into fasting adult subjects at a rate of 25 mg. a minute. Plasma samples were obtained before the injection and at 5, 15, and 30 minutes, one hour, hourly from two to eight hours, and 10 hours, timed from the end of the 10-minute injection period. They were frozen and stored until estimated.
Subjects.-Ten subjects had oral and four subjects had intravenous tolerance tests. They were either patients with epilepsy about to start anticonvulsants or volunteer long-stay neurological patients.
Estimation of Plasma Phenytoin.-Plasma phenytoin levels were estimated by the method of Svensmark and Kristensen (1963) . The phenytoin was extracted by chloroform from acidified plasma and then re-extracted into a phosphate buffer of pH 11.5. The concentration of drug was measured by ultraviolet spectrophotometry and compared with a known standard.
RESULTS
The oral tolerance test from one of our subjects is shown in Fig. 1 . The most striking feature is the biphasic nature of the curve. After a rise to 9 .g./ml. one hour after ingestion of phenytoin the plasma level fell to 3 ,ug./ml. at two hours and 10 700mg. Phenytoin orally rose again tot 9-10 ,ug./ml. between three and four hours; the level then fell progressively. In all 10 oral tolerance tests a similar biphasic curve was seen. The oral tolerance test results for the 10 subjects studied are shown in the Table. In 
